Case report shows Manasmitra vatakam reduces TSH levels in hypothyroidism, suggesting neuroendocrine benefits.
Introduction: Hypothyroidism is a multifactorial endocrine disorder Increasingly linked to dysregulation of the neuroendocrine axis and psychological stress common posing challenges in holistic management. Main clinical findings: A female presented with elevated thyroid stimulating hormone (TSH) levels and significant stress. Diagnosis: Hypothyroidism with associated Agnimandya and manasik involvement was established. Intervention: Management included Manasmitra vatakam as the principal drug, along with Kanchanar Guggulu, Hanspathyadi kashaya and Triphala churna. Outcome: Over three months, TSH levels reduced from 10.5µIU/mL to 4.47µIU/mL with noticeable improvement in stress and overall wellbeing. Conclusion: The observed outcome indicates a plausible neuroendocrine modulatory role of Manasmitra vatakam via Hypothalamus-pituitary-thyroid axis, potentially mediated through stress access regulation influencing thyroid function. This case holds significance of integrating Manasika Chikitsa in the management of hypothyroidism.
No takes yet. Share an insight, caveat, or question.
2Dr. Mahesh H. Pandey *1Dr. Nandita R. Arora (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: